Procedure
circumferential pulmonary vein isolation
Total Trials
2
Max Phase
—
Type
PROCEDURE
Molecule
—
Success Metrics
Active Trials
0(0%)
Phase Distribution
Ph not_applicable
1
50%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
2
all time
Status Distribution
Other(2)
Detailed Status
unknown2
Development Timeline
Analytics
Development Status
Total Trials
2
Active
0
Success Rate
N/A
Most Advanced
N/A
Trials by Phase
N/A1 (100.0%)
Trials by Status
unknown2100%
Recent Activity
0 active trials
Showing 2 of 2
unknown
The Impact of Autonomic Function on Atrial Fibrillation Recurrence After Pulmonary Vein Ablation
NCT06202209
unknownnot_applicable
Comparison of Circumferential Pulmonary Vein Isolation Alone Versus Linear Ablation in Addition to Circumferential Pulmonary Vein Isolation for Catheter Ablation in Persistent Atrial Fibrillation: Prospective Randomized Controlled Trial
NCT02721121
Clinical Trials (2)
Showing 2 of 2 trials
NCT06202209
The Impact of Autonomic Function on Atrial Fibrillation Recurrence After Pulmonary Vein Ablation
NCT02721121Not Applicable
Comparison of Circumferential Pulmonary Vein Isolation Alone Versus Linear Ablation in Addition to Circumferential Pulmonary Vein Isolation for Catheter Ablation in Persistent Atrial Fibrillation: Prospective Randomized Controlled Trial
All 2 trials loaded
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 2